ENDRA Life Sciences Inc. · NASDAQ:NDRA

ENDRA Life Sciences Inc. financial statements

ENDRA Life Sciences Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue00000006.17K351.6K515.6K
Cost of revenue206.2K275.5K234.3K224.4K000172.8K235.9K
Gross profit-206.2K-275.5K-234.3K-224.4K006.17K178.8K279.7K
Research and development1.85M3.19M5.00M6.55M5.48M5.92M6.57M4.72M1.93M495.4K
Selling, general and administrative3.72M7.06M4.70M5.17M4.94M5.00M3.86M3.75M2.75M1.54M
Operating income-5.76M-10.8M-10.5M-13.2M-11.5M-11.5M-10.8M-9.02M-4.63M-1.79M
Depreciation and amortization44.0K46.5K123.7K96.7K116.2K99.3K80.6K68.3K61.5K64.9K
EBITDA-5.72M-10.8M-10.4M-13.1M-11.4M-11.4M-10.8M-8.95M-4.56M-1.73M
Interest expense21.5K267.1K232.4K2.36M042.6K72.0K
Income before tax-7.03M-11.5M-10.1M-13.2M-11.2M-11.7M-13.3M-9.80M-5.38M-2.78M
Income tax000000000
Net income-7.03M-11.5M-10.1M-13.2M-11.2M-11.7M-13.3M-9.80M-5.38M-2.78M
Earnings per share, basic-8.93-56.94-1,694.50-4.56-5.55-0.63-2.34-2.17-1.95-3.84
Earnings per share, diluted-8.93-56.94-2,766.85-0.63-2.34-2.17-1.95-3.84

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents762.4K3.23M2.83M4.89M9.46M7.23M6.17M6.47M5.60M145.0K
Receivables-2.62M-1.35M390.8K116.7K06.85K0
Inventory002.62M2.64M1.28M589.6K113.4K59.4K191.7K40.1K
Current assets968.0K3.43M3.03M5.38M12.1M8.21M6.54M6.95M5.88M195.6K
Property, plant and equipment42.5K69.3K111.8K235.7K131.1K212.2K236.3K273.2K241.5K295.2K
Total assets3.85M4.45M6.75M9.27M12.9M8.76M7.18M7.22M6.12M490.8K
Accounts payable383.0K269.7K360.4K614.0K791.1K402.9K1.28M631.5K780.3K227.7K
Current liabilities751.0K605.2K903.1K1.70M1.54M986.7K2.07M974.6K848.2K1.38M
Long-term debt28.5K337.1K
Total debt492.4K028.5K28.5K546.6K769.3K773.3K23950.0K
Total liabilities1.59M1.89M1.10M2.07M2.09M1.60M2.42M974.6K848.2K1.38M
Shareholders' equity2.26M2.56M5.66M7.20M10.8M7.17M4.76M6.25M5.28M-893.8K
Shares outstanding1.18M536.9K5.94K3.17M2.13M34.0M8.42M7.42M3.92M723.3K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-5.18M-7.40M-9.55M-12.8M-11.1M-10.7M-8.59M-7.70M-3.30M-1.32M
Capital spending-17.3K-16.0K-33.9K-202.6K-45.0K-75.3K-43.6K-100.0K-7.86K-7.86K
Free cash flow-5.20M-7.42M-9.58M-13.0M-11.2M-10.8M-8.63M-7.80M-3.31M-1.32M
Cash from investing-3.02M-12.8K-24.7K-202.6K-45.0K-75.3K-43.6K-100.0K-7.86K0
Cash from financing5.73M7.81M7.52M8.40M13.4M11.9M8.34M8.67M8.77M1.44M
Dividends paid-5.23K-840-7.79K-121.1K-395.6K-4.22M
Share buybacks11.5M5.84M7.74M8.59M5.00K
Change in cash-2.47M395.6K-2.06M-4.57M2.23M1.05M-297.2K869.5K5.46M125.8K